V-Card | Print | PDF | Email Page

A. Patricia Campbell Ph.D.
Partner

Contact

(T) +1.650.687.4138
(F) +1.650.739.3900

Education

  • University of Washington (Seattle) (J.D. 2007); Protein Engineering Network of Centres of Excellence (Edmonton) (Postdoctoral Fellow, 1993-1997); Scripps Research Institute, Department of Molecular Biology (La Jolla, California) (Postdoctoral Fellow, 1992-1993); University of Alberta (Edmonton, Canada) (Ph.D. in Biochemistry 1992); University of British Columbia (Vancouver, Canada) (B.Sc. in Biochemistry and Chemistry with honors 1984)

Bar Admissions

  • California, U.S. District Court for the Northern District of California, and registered to practice before the U.S. Patent and Trademark Office

Patricia Campbell has more than 10 years of experience counseling clients in all aspects of patent portfolio development in the pharmaceutical and biotechnology sectors. This includes for small molecule pharmaceuticals, antibodies and antibody-drug conjugates, diagnostics, enzyme replacements, and in silico screening methods for drug identification and development, among others. She has prosecuted some of the most valuable patent portfolios covering approved products from several of the world's premier biotechnology/pharmaceutical companies.

In addition to patent procurement and portfolio management, Patricia advises clients regarding patentability, validity, infringement, and freedom-to-operate issues and performs due diligence evaluations of patent portfolios for possible investment, licensing, or acquisition. She also has experience with inter partes review proceedings and oppositions before the European Patent Office. Her representative life sciences clients include AbbVie, BioMarin Pharmaceutical, Genentech, NGM Biopharmaceuticals, and Jazz Pharmaceuticals, as well as other start-up companies, established companies, academic institutions, and investment firms.

Prior to practicing law, Patricia was a tenured associate professor in the Department of Medicinal Chemistry at the University of Washington, where she served as principal investigator on research projects funded by the National Institutes of Health and the Department of Defense. Her research programs included structure-based drug design and mechanistic studies of drug-drug interactions.

Patricia is a member of the American Bar Association and the IP Inn of Court.


A. Patricia Campbell Patricia